These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11880199)
1. Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick's disease. Kim SH; Krapfenbauer K; Cheon MS; Fountoulakis M; Cairns NJ; Lubec G Neurosci Lett; 2002 Mar; 321(3):169-72. PubMed ID: 11880199 [TBL] [Abstract][Full Text] [Related]
2. Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease. Schneider C; Risser D; Kirchner L; Kitzmüller E; Cairns N; Prast H; Singewald N; Lubec G Neurosci Lett; 1997 Feb; 222(3):183-6. PubMed ID: 9148245 [TBL] [Abstract][Full Text] [Related]
4. Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer's and Pick's disease. Miguel RF; Pollak A; Lubec G Brain Res Mol Brain Res; 2005 Jan; 133(1):1-5. PubMed ID: 15661359 [TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Krapfenbauer K; Engidawork E; Cairns N; Fountoulakis M; Lubec G Brain Res; 2003 Mar; 967(1-2):152-60. PubMed ID: 12650976 [TBL] [Abstract][Full Text] [Related]
6. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Shim KS; Lubec G Neurosci Lett; 2002 May; 324(3):209-12. PubMed ID: 12009525 [TBL] [Abstract][Full Text] [Related]
7. Neuronal and vascular localization of histamine N-methyltransferase in the bovine central nervous system. Nishibori M; Tahara A; Sawada K; Sakiyama J; Nakaya N; Saeki K Eur J Neurosci; 2000 Feb; 12(2):415-24. PubMed ID: 10712622 [TBL] [Abstract][Full Text] [Related]
8. Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease. Pollak D; Cairns N; Lubec G J Neural Transm Suppl; 2003; (67):149-58. PubMed ID: 15068247 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological study of two subtypes of Pick's disease in Japan. Odawara T; Iseki E; Kanai A; Arai T; Katsuragi T; Hino H; Furukawa Y; Kato M; Yamamoto T; Kosaka K Dement Geriatr Cogn Disord; 2003; 15(1):19-25. PubMed ID: 12457075 [TBL] [Abstract][Full Text] [Related]
12. Functional increase of brain histaminergic signaling in Huntington's disease. van Wamelen DJ; Shan L; Aziz NA; Anink JJ; Bao AM; Roos RA; Swaab DF Brain Pathol; 2011 Jul; 21(4):419-27. PubMed ID: 21106039 [TBL] [Abstract][Full Text] [Related]
13. Histamine and histamine-N-methyltransferase in the goat brain. Tuomisto L; Eriksson L Agents Actions; 1982 Apr; 12(1-2):142-5. PubMed ID: 7080949 [TBL] [Abstract][Full Text] [Related]
14. Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease. Kim SH; Cairns N; Fountoulakisc M; Lubec G Neurosci Lett; 2001 Mar; 300(1):41-4. PubMed ID: 11172935 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716 [TBL] [Abstract][Full Text] [Related]
16. Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Yamauchi K; Sekizawa K; Suzuki H; Nakazawa H; Ohkawara Y; Katayose D; Ohtsu H; Tamura G; Shibahara S; Takemura M Am J Physiol; 1994 Sep; 267(3 Pt 1):L342-9. PubMed ID: 7943261 [TBL] [Abstract][Full Text] [Related]
17. Preservation of nigral neurons in Pick's disease with Pick bodies: a clinicopathological and morphometric study of five autopsy cases. Yokota O; Ishizu H; Terada S; Tsuchiya K; Haraguchi T; Nose S; Kawai K; Ikeda K; Kuroda S J Neurol Sci; 2002 Feb; 194(1):41-8. PubMed ID: 11809165 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of adenosine A1 receptors in frontal cortex from Pick's disease cases. Albasanz JL; Rodríguez A; Ferrer I; Martín M Eur J Neurosci; 2007 Dec; 26(12):3501-8. PubMed ID: 18052973 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies for human and porcine histamine N-methyltransferase (HMT) facilitate protein expression and localization studies. Schwelberger HG; Feurle J; Houen G Inflamm Res; 2017 Jan; 66(1):67-77. PubMed ID: 27632021 [TBL] [Abstract][Full Text] [Related]
20. Expression of transcription factors c-Fos, c-Jun, CREB-1 and ATF-2, and caspase-3 in relation with abnormal tau deposits in Pick's disease. Nieto-Bodelón M; Santpere G; Torrejón-Escribano B; Puig B; Ferrer I Acta Neuropathol; 2006 Apr; 111(4):341-50. PubMed ID: 16496165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]